Liminatus Pharma, Inc. (LIMNW) — S-1/A Filings
All S-1/A filings from Liminatus Pharma, Inc.. Browse 1 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (1)
-
Liminatus Pharma's S-1/A Reveals Growing Deficit Amidst Restructuring
— Jul 28, 2025 Risk: high
Liminatus Pharma, Inc. (LIMNW) filed an S-1/A on July 28, 2025, detailing its financial position and ongoing corporate restructuring. The company, formerly Iris
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX